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Despite significant advancements in bone tissue engineering applications, the 
clinical impact of bone marrow stromal cells (BMSCs) for the treatment of large 
osseous defects remains limited. Therefore, other cell sources are under investiga-
tion for their osteogenic potential to repair bone. In this study tendon-derived stro-
mal cells (TDSCs) were evaluated in comparison to BMSCs to support the functional 
repair of a 5mm critical-sized, segmental defect in the rat femur. 
Analysis of the trilineage differentiation capacity of TDSCs and BMSCs cultured 
on collagen sponges revealed an impaired osteogenic differentiation and mineral 
deposition of TDSCs in vitro, whereas chondrogenic and adipogenic differentiation 
was evident for both cell types. Radiographic assessment demonstrated that neither 
cell type significantly improved the healing rate of a challenging 5mm segmental 
femoral defect in vivo. Both, transplanted TDSCs and BMSCs led to the formation 
of only small amounts of bone in the defect area and histological evaluation revea-
led non-mineralized, collagen- rich scar tissue to be present within the defect area. 
Newly formed lamellar bone was restricted to the defect margins resulting in clo-
sure of the medullary cavity. Interestingly, in comparison to BMSCs, significantly 
more TDSC-derived cells were present at the osteotomy gap up to 8 weeks after 
transplantation and were also found to be located wihin newly formed lamellar 
bone, suggesting their capacity to directly contribute to de novo bone formation. To 
our knowledge this is the first study investigating the in vivo capacity of TDSCs to 
regenerate a critical-sized defect in the rat femur. 
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